CClinicalTrials.gg
CompletedNCT03684590Updated Apr 30, 2025Results posted

ANI Versus Standard Care in Surgical Patients Receiving Balanced Sevoflurane-Fentanyl Anesthesia

An interventional study of ANI-guided opioid administration and Standard opioid administration in Acute Pain, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-30.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to be a randomized, controlled study of ANI-guided opioid administration versus standard clinical practice in surgical patients undergoing general anesthesia with balanced sevoflurane-fentanyl. Patients will be randomly assigned to 2 groups- ANI vs. standard care. The intraoperative and postoperative management of all patients will be standardized by protocol. The PACU nurses and postop assessor will be blinded as to which group the patient is in.

02

Conditions studied

  • Acute Pain

Browse trials for

03

In context

Acute Pain

876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.

This study's enrollment of 102 is above the median of 90 across 732 interventional studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

University of Texas Southwestern Medical Center is the lead sponsor of 990 studies on the registry; 201 are open to participants now.

Of its 135 completed or terminated interventional studies of FDA-regulated products, 100 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18-75 years old
  • ASA 1-2
  • BMI 19-35 kg/m2
  • Patients undergoing surgery with general anesthesia with sevoflurane- fentanyl
  • Planned abdominal or spinal surgery lasting 1-3 hours
  • Willing and able to consent in English or Spanish
  • No current history of advanced pulmonary or cardiovascular disease

Exclusion criteria

Exclusion Criteria:

  • Age less than 18 or older than 75
  • Patient does not speak English or Spanish
  • Patient refusal
  • Monitored anesthesia care (MAC) or regional anesthesia planned
  • Pregnant or nursing women
  • "Stat" (emergent) cases
  • ECG rhythm other than regular sinus rhythm
  • Implanted pacemakers
  • On antimuscarinic agents, alpha 2 agonists, antiarrhythmics, or beta blockers
  • Presence of pacemaker
  • Autonomic nervous system disorder
  • Use of chronic opioids
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
102 participants (actual)

Study arms

  • Active comparator
    Standard opioid administration

    Intraoperative opioid will be administered by guiding standard practice

    Other: Standard opioid administration

  • Experimental
    ANI-guided opioid administration

    Intraoperative opioid will be administered based on the analgesia nociceptive index (ANI)

    Device: ANI-guided opioid administration

Interventions

  • DeviceANI-guided opioid administration

    Intraoperative opioid will be administered guided by analgesia nociceptive index (ANI) values measured by ANI monitor (MetroDoloris Medical Systems, Lille, France)

  • OtherStandard opioid administration

    Intraoperative opioid will be administered according to standard practice during surgery.

06

What researchers measure

Primary outcomes

  1. The Incidence of Severe Postoperative Pain

    The primary outcome will be the NRS pain scores reported during recovery

    Time frame: postoperative recovery period, an average of 1 hour

Secondary outcomes

  1. The Incidence of Pain Medication Use

    The total amounts of opioid analgesics administered in the operating room (OR) and post-anesthesia care unit (PACU)

    Time frame: Perioperative and postoperative recovery period

  2. The Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)

    The incidence of nausea/vomiting reported during recovery

    Time frame: Postoperative recovery period

  3. The Incidence of Minimal Pain

    The percent of subjects with minimal pain (NPS \< 3) in post-anesthesia care unit (PACU)

    Time frame: Postoperative recovery period

07

Results

Posted Jun 12, 2024

Participant flow

Participant flow — Overall Study
MilestoneStandard Opioid AdministrationANI-guided Opioid Administration
Started4953
Completed4953
Not completed00

Outcome measures

PrimaryThe Incidence of Severe Postoperative Pain

The primary outcome will be the NRS pain scores reported during recovery

Time frame:
postoperative recovery period, an average of 1 hour
Reported as:
Count of participants · Participants
The Incidence of Severe Postoperative Pain
ParticipantsStandard Opioid AdministrationANI-guided Opioid Administration
The Incidence of Severe Postoperative Pain4953
SecondaryThe Incidence of Pain Medication Use

The total amounts of opioid analgesics administered in the operating room (OR) and post-anesthesia care unit (PACU)

Time frame:
Perioperative and postoperative recovery period
Reported as:
Mean · micrograms
The Incidence of Pain Medication Use
microgramsStandard Opioid AdministrationANI-guided Opioid Administration
The Incidence of Pain Medication Use224.1 ± 140.5294.4 ± 170.3
SecondaryThe Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)

The incidence of nausea/vomiting reported during recovery

Time frame:
Postoperative recovery period
Reported as:
Count of participants · Participants
The Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)
ParticipantsStandard Opioid AdministrationANI-guided Opioid Administration
The Incidence of Postoperative Nausea/Vomiting in Post-anesthesia Care Unit (PACU)00
SecondaryThe Incidence of Minimal Pain

The percent of subjects with minimal pain (NPS \< 3) in post-anesthesia care unit (PACU)

Time frame:
Postoperative recovery period
Reported as:
Count of participants · Participants
The Incidence of Minimal Pain
ParticipantsStandard Opioid AdministrationANI-guided Opioid Administration
The Incidence of Minimal Pain1222

Adverse events

Collected over 24 hours post-op. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Opioid Administration0/49 (0%)0/49 (0%)0/49 (0%)
ANI-guided Opioid Administration0/53 (0%)0/53 (0%)0/53 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Standard Opioid AdministrationANI-guided Opioid AdministrationTotal
<=18 years000
Between 18 and 65 years4952101
>=65 years011
Age, Continuous
Age, Continuous(years)Standard Opioid AdministrationANI-guided Opioid AdministrationTotal
Mean42.69 (23 to 61)45.31 (29 to 67)43.87 (23 to 67)
Sex: Female, Male
Sex: Female, Male(Participants)Standard Opioid AdministrationANI-guided Opioid AdministrationTotal
Female4952101
Male011
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Standard Opioid AdministrationANI-guided Opioid AdministrationTotal
Hispanic or Latino313768
Not Hispanic or Latino181634
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Standard Opioid AdministrationANI-guided Opioid AdministrationTotal
United States4953102
08

Study locations

1 site
  • Parkland Health & Hospital System
    Dallas, Texas 75235, United States
09

References and documents

Publications

  • Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013 Apr;118(4):934-44. doi: 10.1097/ALN.0b013e31828866b3. PubMed 23392233 ↗
  • Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000 Oct;93(4):1123-33. doi: 10.1097/00000542-200010000-00038. No abstract available. PubMed 11020770 ↗
  • Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003 Aug;97(2):534-540. doi: 10.1213/01.ANE.0000068822.10113.9E. PubMed 12873949 ↗
  • Boselli E, Daniela-Ionescu M, Begou G, Bouvet L, Dabouz R, Magnin C, Allaouchiche B. Prospective observational study of the non-invasive assessment of immediate postoperative pain using the analgesia/nociception index (ANI). Br J Anaesth. 2013 Sep;111(3):453-9. doi: 10.1093/bja/aet110. Epub 2013 Apr 16. PubMed 23592690 ↗
  • Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric surgery. Curr Opin Anaesthesiol. 2016 Jun;29(3):421-9. doi: 10.1097/ACO.0000000000000337. PubMed 26982116 ↗
  • Budiansky AS, Margarson MP, Eipe N. Acute pain management in morbid obesity - an evidence based clinical update. Surg Obes Relat Dis. 2017 Mar;13(3):523-532. doi: 10.1016/j.soard.2016.09.013. Epub 2016 Sep 19. PubMed 27771314 ↗
  • Lovich-Sapola J, Smith CE, Brandt CP. Postoperative pain control. Surg Clin North Am. 2015 Apr;95(2):301-18. doi: 10.1016/j.suc.2014.10.002. Epub 2015 Jan 24. PubMed 25814108 ↗
  • Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014 Jan;30(1):149-60. doi: 10.1185/03007995.2013.860019. Epub 2013 Nov 15. PubMed 24237004 ↗
  • Borsook D, Kussman BD, George E, Becerra LR, Burke DW. Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg. 2013 Mar;257(3):403-12. doi: 10.1097/SLA.0b013e3182701a7b. PubMed 23059501 ↗
  • Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014 Jun;112(6):991-1004. doi: 10.1093/bja/aeu137. PubMed 24829420 ↗
  • Jeanne M, Clement C, De Jonckheere J, Logier R, Tavernier B. Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery. J Clin Monit Comput. 2012 Aug;26(4):289-94. doi: 10.1007/s10877-012-9354-0. Epub 2012 Mar 28. PubMed 22454275 ↗
  • Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Hocker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. Epub 2013 Mar 6. PubMed 23471754 ↗
  • Sabourdin N, Arnaout M, Louvet N, Guye ML, Piana F, Constant I. Pain monitoring in anesthetized children: first assessment of skin conductance and analgesia-nociception index at different infusion rates of remifentanil. Paediatr Anaesth. 2013 Feb;23(2):149-55. doi: 10.1111/pan.12071. Epub 2012 Nov 21. PubMed 23170802 ↗
  • Upton HD, Ludbrook GL, Wing A, Sleigh JW. Intraoperative "Analgesia Nociception Index"-Guided Fentanyl Administration During Sevoflurane Anesthesia in Lumbar Discectomy and Laminectomy: A Randomized Clinical Trial. Anesth Analg. 2017 Jul;125(1):81-90. doi: 10.1213/ANE.0000000000001984. PubMed 28598927 ↗
  • Szental JA, Webb A, Weeraratne C, Campbell A, Sivakumar H, Leong S. Postoperative pain after laparoscopic cholecystectomy is not reduced by intraoperative analgesia guided by analgesia nociception index (ANI(R)) monitoring: a randomized clinical trial. Br J Anaesth. 2015 Apr;114(4):640-5. doi: 10.1093/bja/aeu411. Epub 2014 Dec 23. PubMed 25540069 ↗
  • Dundar N, Kus A, Gurkan Y, Toker K, Solak M. Analgesia nociception index (ani) monitoring in patients with thoracic paravertebral block: a randomized controlled study. J Clin Monit Comput. 2018 Jun;32(3):481-486. doi: 10.1007/s10877-017-0036-9. Epub 2017 Jun 19. PubMed 28631050 ↗

Study documents

  • Protocol and statistical analysis plan · Aug 22, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03684590
Lead sponsor
University of Texas Southwestern Medical Center
Responsible party
Tiffany B Moon (Associate Professor, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Sep 25, 2018
Start date
Jul 30, 2019
Primary completion
Mar 6, 2023
Completion
Mar 6, 2023
Results posted
Jun 12, 2024
Last update
Apr 30, 2025

Study contacts

Tiffany Moon, MD
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion